The percentage of VEGF-positive area significantly increased in the A549 tumor-bearing lung (mock group) and single metformin treatment group; however, single pemetrexed treatment decreased the percentage of VEGF-positive area, which were further decreased in the combination treatment groups (Figure 6D). The gene discussed is VEGFA; the disease is neoplasm.